semaglutide grey GLP-1 Semaglutide + Cagrilintide Combination
Description
It's important to clarify upfront: Spironolactone is currently not approved for weight-loss prescription in the EU, nor is it offered by Hi-Doctor for this indication

Good candidates typically have a BMI over 30, or a BMI of 27 or higher along with one or more weight-related health conditions such as type 2 diabetes, high blood pressure, or high cholesterol

Piles, also called hemorrhoids, are a common reason for discomfort, itching, and bleeding around the anus
GLP-1 combination therapy Researched alongside GLP-1 agonists like semaglutide (CagriSema) in investigational obesity trials, still under study

Gastrointestinal problems are common, particularly when someone first starts taking the drug

Even Medicare, which is prohibited from covering drugs for weight loss, may reconsider their position
